evaluate the health and wellness company onnit on glp-1 Who Can Benefit Most From A Remote Weight Loss Program? Clinically Inspired Formula Why GLP-1 is not the

Kunz, M., Simon, J

5.2 Prospective clinical trial progress and results of tirzepatide in the treatment of type 2 diabetes with cardiovascular disease Currently, two significant cardiovascular outcome trials for tirzepatide are underway (or have recently concluded), including SURPASS-CVOT and SUMMIT

Follow-up Repeat broad labs after 8-12 weeks if systemic use continues or symptoms change

Additionally, the average number of sessions needed to achieve desired results varies from two to four appointments

Do not reuse needles or devices that are intended for single use

Note: There are also emerging alternatives to GLP-1 medications